Why is ATTR difficult to diagnose?

• A. Its main symptoms overlap with other diseases
• B. It presents with a unique biomarker
• C. It occurs only after age 100
• D. It is rapidly fatal before diagnosis

Answer: (A)

ATTR is hard to diagnose because its symptoms closely resemble those of many other conditions. When the heart is involved, patients may show heart failure with preserved ejection fraction or rhythm problems, which are common in other cardiomyopathies. When nerves are affected, the picture can look like diabetic neuropathy or other neuropathies. This overlap means clinicians must look beyond a single finding and piece together information from multiple tests.

There isn’t a universal, definitive biomarker that confirms ATTR across all patients. Instead, diagnosis relies on a combination of tools: imaging that supports ATTR cardiomyopathy (such as bone-avid radiotracers in the right clinical setting), blood and urine tests to rule out light-chain amyloidosis, tissue biopsy with Congo red staining to demonstrate amyloid deposits, and genetic testing to distinguish hereditary ATTR from wild-type ATTR. This multi-test approach is necessary because relying on symptoms alone could lead to misdiagnosis or missed cases.

The other statements aren’t correct because there isn’t a unique biomarker, the condition isn’t restricted to people over 100, and while it can be serious, it isn’t invariably rapidly fatal before diagnosis.